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Enteric fever (typhoid) is classically caused
by Salmonella enterica serotype Typhi, but a
similar syndrome may be observed with
S. Paratyphi A and other serotypes. Outbreaks of
enteric fever associated with S. Paratyphi A have
rarely been reported in India (1–3). Although
multidrug-resistant outbreaks of S. Typhi with
an increase in numbers of strains with decreased
susceptibility to ciprofloxacin have occurred,
cases of drug-resistant S. Paratyphi A have been
relatively uncommon (2).  We report a sudden
increase in enteric cases caused by drug-
resistant  S.  Paratyphi A unresponsive to
ciprofloxacin therapy.
The Study
We screened all recent isolates of S. Paratyphi
A from hospitals in Delhi and adjoining areas for
susceptibility (MICs) to various drugs. A total of
105 sporadic isolates of S. Paratyphi A from All
India Institute of Medical Sciences (67 isolates),
Safdarjang  Hospital (31 isolates), New Delhi and
Rohtak Medical College, Haryana (7 isolates) (an
Indian state near New Delhi) were collected from
April 1996 to July 1999 and tested for
susceptibility to chloramphenicol, cotrimoxazole,
amoxicillin, and ciprofloxacin by comparative
disc diffusion (4). MICs to ciprofloxacin were
estimated by E-test (AB-Biodisc, Sweden) accord-
ing to guidelines from the National Committee for
Clinical Laboratory Standards (NCCLS).
In the study period, S. Paratyphi A isolations
in enteric fever cases were 10, 16, 57, and 22, in
1996 (April), 1997, 1998, and 1999 (through July),
respectively. During 1996-97, isolates were
uniformly susceptible to all antibiotics, including
ciprofloxacin and ceftriaxone, commonly used in
the treatment of enteric fever. However, in 1998,
the incidence of enteric fever caused by drug-
resistant S. Paratyphi A abruptly increased (up
to 24% of isolates), and the number of drug-
resistant isolates susceptible to ciprofloxacin
markedly decreased. MICs of 0.25 to 1.5 mg/L
were recorded (Table). In the first 6 months of
1999, 7 (32%) of 22 isolates were resistant to both
chloramphenicol and cotrimoxazole and another
3 (13%) were resistant to more than two drugs.
Compared with isolates from 1996 to 1998, most
drug-resistant isolates in 1999 showed higher
MICs to ciprofloxacin.
Conclusions
S. Paratyphi A, which causes 1%-15% of
enteric fever cases in India, has been increasing
since 1996 (3). Our study found that 32% of
isolates from the New Delhi region had decreased
susceptibility to ciprofloxacin (MIC >2.0 mg/L),
the drug of choice for enteric fever in India. One
sequela of this increased resistance was delay in
the resolution of symptoms. Although strains
may appear sensitive at this level, when subjected
to ciprofloxacin-susceptibility testing by disc
diffusion, treatment failure may still occur.
The mechanisms proposed for quinolone
resistance involve alteration in the permeability
of the drug (outer membrane protein gene
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 The incidence of enteric fever caused by Salmonella enterica serotype Paratyphi
A has been increasing in India since 1996. In 1998, the incidence of enteric fever caused
by drug-resistant S. Paratyphi A abruptly increased in the New Delhi region.  In the first
6 months of 1999, 32% of isolates were resistant to both chloramphenicol and
cotrimoxazole and another 13% were resistant to more than two antibiotics.Dispatches
421 Vol. 6, No. 4, July–August 2000 Emerging Infectious Diseases
Table. Resistance pattern and ciprofloxacin MIC of Salmonella Paratyphi A isolates, New Delhi, India, 1996–1999
Drug-resistance pattern Ciprofloxacin
Cl+  MIC
Strains Cl+ Cz+  Range  Total
Year   (no.) Cl Cz Ax Cp Cz Ax Total (%)  (mg/L)    (%)
1996 10  -  -  -  -  1  -    1 (10) <0.0025   -
1997 16  2  -  -  -  1  -    3 (18) <0.045   -
1998 57  - 11  -  -   -  3  14 (24)   0.25-1.5 12 (21)
1999a 22  -  -  -  -  7  3  10 (45)   2.0   7 (32)
auntil July 1999.
- = sensitive range; Cl=chloramphenicol; Cz=cotrimoxazole; Ax=amoxicillin; Cp=ciprofloxacin.
mutation) or alteration of the target enzyme DNA
gyrase (5) within the treated bacterium as its
adaptive reflex.  Since resistance to quinolones is
independent of resistance to other drugs that are
mainly plasmid mediated, it may occur in
otherwise sensitive strains.  Similar R-plasmids
of the IncHi Group have been documented: four
strains of drug-resistant S. Paratyphi A were
shown to harbor such plasmids encoding
transferrable resistance to many drugs (ampicil-
lin, chloramphenicol, sulfamethoxazole, and
tetracycline) other than ciprofloxacin (6). The
incidence of plasmids conferring multidrug
resistance is increasing in Salmonella serotypes,
including Enterobacteriaceae, where transfer of
these R-plasmids to S. Paratyphi A strains may
have occurred. Continuous surveillance for the
susceptibility patterns of current isolates is needed.
However, development of resistance to
ciprofloxacin has been suggested as partly
related to exposures of these organisms to
concentrations near their MICs. With increases
in MICs, clinicians may be tempted to administer
higher doses of ciprofloxacin to achieve serum
levels required for effective therapy; however,
higher doses could have unwanted clinical and
public health consequences. Rather, this in-
creased resistance may warrant a restructuring
of the chemotherapeutic regimen for enteric
diseases, as well as restricting use of ciprofloxacin
to atypical cases in which lack of clinical response
to other therapeutic drugs is noted.
Chloramphenicol and amoxicillin may need
to be reconsidered as the drugs of choice in cases
of enteric fever because of the increased
susceptibilities of such cases to these drugs
(>90% for reemerging isolates of S. Typhi [3]).
However, these recommendations might not be
appropriate in view of the substantial increase in
drug-resistant S. Paratyphi A infections, which
often obfuscate the clinical diagnosis and manage-
ment of enteric fever. The increase in incidence of
enteric fever caused by S.  Paratyphi A could
possibly be related to widespread use of vaccines
and quinolones against S. Typhi in the past
decade. Regardless, the frequency and geo-
graphic diversity of these cases increase the
potential for large outbreaks of drug-resistant
S. Paratyphi A in India.
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